Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis Virus Hits Kitgum District
(New Vision/All Africa Global Media via COMTEX News Network) -- A Total of 1,262 cases of the new Hepatitis E virus have been reported in Kitgum District. The health ministry announced on Friday that of these, 25 have died and the virus has spread to

77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS - Seventy-seven more people who were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist

Free Hepatitis Testing
Your Opinion Matters


UPDATES AND COMMENTARY RSS Feed

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

Age at infection of Hepatitis C virus and risk of hepatocellular carcinoma in cirrhosis

T. Suou, H. Tanaka, A. Mitsuda, K. Miura, T. Yamamoto, H. Kawasaki Japan

The aim of this study was to assess whether the age at the time of Hepatitis C virus (HCV) infection was associated with an increased risk of hepatocellular carcinoma (HCC) after the infection. A total of 139 patients with HCV-related cirrhosis and a history of a blood transfusion were evaluated for the development of HCC after the time of blood transfusion.

Multivariant regression analysis of the study results showed that the age at transfusion was the most important risk factor associated with the development of HCC after the initial blood transfusion (odds ratio 6.03, p Less Than 0.0001). Other independent risk factors were the age at the diagnosis of cirrhosis (odds ratio 3.23, p Less Than 0.01) and male sex (odds ratio 2.22, p Less Than 0.05), although HCV genotype, HCV RNA level, alcohol intake and smoking were not related the carcinogenesis.

The mean age of the patients was 61 years (range, 35 to 84) at the time of diagnosis. The mean age at the time of blood transfusion was 36 years (range, 7 to 69), and the mean interval between the time of blood transfusion and the diagnosis of cirrhosis was 25 years (range, 5 to 50). The interval correlated negatively with the age at transfusion (r = -0.645, p Less Than 0.0001) and positively with the age at diagnosis (r = 0.356, pLess Than 0.0001). After a 5.4 year follow up, HCC developed in 54 (39 per cent) of the patients.

The Japanese team suggests that HCV infection in old patients induces a rapid progression to HCC independent of HCV genotype.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 12 May 2008